OnKure Therapeutics OKUR
NASDAQ OKUR
$2.54 -0.04 (-1.55%)
As of: Oct 23, 2026 · 2:53 PM EDT

OnKure Therapeutics (OKUR) Other Non Operating Income (2020 - 2024)

Updated

OnKure Therapeutics (OKUR) posted Other Non Operating Income of $972,000 for Q3 2024, down 42.6% from $1.69 million a year earlier and down 3.1% from the prior quarter.

Analysis

OnKure Therapeutics (OKUR) Other Non Operating Income (2020 - 2024) Analysis & Trends

For the trailing twelve months through Sep 30, 2024, Other Non Operating Income at OnKure Therapeutics was $4.57 million, down 11.8% year-over-year; for FY2023, it came in at $5.67 million, up 199.3% from FY2022.

  • Annual Other Non Operating Income shows a three-year compound annual growth rate of 302.3% (FY2020 to FY2023).
  • In prior years, OnKure Therapeutics' Other Non Operating Income was $1.89 million in FY2022, $48,000 in FY2021 (-44.8%) and $87,000 in FY2020.
  • The Q3 2024 figure stands as the lowest quarterly Other Non Operating Income since Q4 2022.
  • On a year-over-year basis, Other Non Operating Income increased in three of the last five quarters, with growth averaging 18.0%.
  • The strongest year-over-year quarter for Other Non Operating Income in the past five years was Q2 2022, with growth of 891.7%; the weakest was Q1 2021, with a decline of 97.2%.
  • According to Business Quant data, Other Non Operating Income for the three prior quarters was $1 million (Q2 2024), $1.14 million (Q1 2024) and $1.45 million (Q4 2023).
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Eli Lilly 1,127.89 Bn 1,096.47 Bn 19.71 Bn
2 Johnson & Johnson 635.11 Bn 554.97 Bn 17.30 Bn
3 AbbVie 504.69 Bn 477.80 Bn 12.70 Bn
4 Merck 358.24 Bn 312.62 Bn 12.21 Bn
5 Novartis Ag 290.13 Bn 254.12 Bn 11.24 Bn
6 Astrazeneca 265.05 Bn 238.74 Bn 12.86 Bn
7 Amgen 237.87 Bn 193.27 Bn 7.24 Bn
8 Gilead Sciences 194.91 Bn 169.11 Bn 6.22 Bn
9 Pfizer 171.28 Bn 117.93 Bn 10.94 Bn
10 OnKure Therapeutics 126.67 Mn -371.26 Mn -
Historic Data

Historic Data

Download Data
DateValue
Sep 30, 2024 972,000.00
Jun 30, 2024 1.00 Mn
Mar 31, 2024 1.14 Mn
Dec 31, 2023 1.45 Mn
Sep 30, 2023 1.69 Mn
Jun 30, 2023 1.51 Mn
Mar 31, 2023 1.02 Mn
Dec 31, 2022 962,000.00
Sep 30, 2022 833,000.00
Jun 30, 2022 119,000.00
Mar 31, 2022 -21,000.00
Dec 31, 2021 17,000.00
Sep 30, 2021 17,000.00
Jun 30, 2021 12,000.00
Mar 31, 2021 2,000.00
Dec 31, 2020 -2,000.00
Sep 30, 2020 5,000.00
Jun 30, 2020 12,000.00
Mar 31, 2020 71,000.00
API Access

OnKure Therapeutics Other Non Operating Income API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=other-non-operating-income&ticker=OKUR&period=max&api_key=YOUR_API_KEY